Shaman Pharmaceuticals
Executive Summary
Goes public Jan. 27 with offering of 3 mil. shares at $15 per share. Shaman uses its screening technology to develop pharmaceuticals derived from tropical plants with histories of medical utility ("The Pink Sheet" Oct. 26, 1992, T&G-9).